Here's Why Corcept Therapeutics (NASDAQ:CORT) Has Caught The Eye Of Investors

Simply Wall StJan 2 02:39

Sector Update: Health Care Stocks Flat to Higher Premarket Tuesday

MT NewswiresDec 31, 2024 21:58

Corcept Therapeutics Files New Drug Application for Relacorilant

MT NewswiresDec 31, 2024 06:42

Corcept Therapeutics Submits New Drug Application To FDA For Its Proprietary, Selective Cortisol Modulator, Relacorilant, To Treat Patients With Cushing's Syndrome

BenzingaDec 31, 2024 06:16

Express News | Corcept Submits New Drug Application for Relacorilant as a Treatment for Patients With Hypercortisolism

BreakingsDec 31, 2024 06:15

Will Corcept Therapeutics Incorporated (CORT) Make You Rich In 2025?

Yahoo FinanceDec 25, 2024 12:13